UNC Researchers Develop New Way To Measure Acid Level Of Body Fluids

November 11, 1998

CHAPEL HILL, N.C. - Scientists at the University of North Carolina at Chapel Hill have invented a solid-state metal sensor -- roughly the thickness of three human hairs -- that can measure the acidity (pH) of chemical solutions, including body fluids.

A report describing the invention, including successful laboratory tests in animals, is published in the December issue of Analytical Chemistry.

"This particular electrode can be applied to any solution ? from a chemical process in the laboratory to the measurement of tissue pH in physiologic studies," says co-inventor Dr. Wayne E. Cascio, associate professor of medicine at the UNC-CH School of Medicine.

But according to new findings by Cascio and his UNC-CH colleagues, the pH electrode may even prove useful for monitoring the hearts of hospitalized patients, especially those in intensive coronary care. Attached to the tip of a catheter and then threaded via vein to the heart, the pH electrode may offer advance warning when cardiac muscle is becoming more acidic, a condition that occurs during ischemia. Ischemia takes place when the supply of oxygen is cut to portions of the heart and can arise from fat-clogged coronary arteries. This condition could lead to a heart attack.

"If the pH is falling, indicating more acidity, then you know that the tissue is ischemic," Cascio, a cardiologist, explains. "The process of ischemia generates acid, and the degree of acidification offers an index of the severity of ischemia. But a falling pH also seems linked to other electrical and metabolic changes that occur and can predispose to heart rhythm disturbances such as ventricular fibrillation and sudden death," he adds.

In terms of pH in the human body, metabolic actions occur properly when fluids are close to chemical neutrality ? neither too acid nor too alkaline. On a scale of zero to 14, a pH of below 7 signals acidity. In cardiac tissue, ischemia results in the loss of protons from cells, which leads to increased acidity.

Currently, measures of pH typically require glass electrodes. Though stable and reliable, these thin-walled glass bulbs are too large for use in the blood vessels and heart.

The recently invented electrodes have a working lifetime of at least one month and are highly accurate (within about two hundredths of a pH unit) and respond rapidly. They also were shown insensitive to the effects of fluid changes in sodium, potassium, calcium, magnesium, lactate, dissolved oxygen, ascorbate, and urate, which are important for physiological applications in medicine, biotechnology, and drug development.

Cascio and his co-authors explain that the pH electrode is a layer of iridium oxide bonded by electroplating to a platinum surface. This is then covered with a protective polymer. The electrode can be bonded to a variety of materials. According to Cascio, it would be "fairly simple" to attach a pH electrode to the type of catheter commonly used for studying the electrical activity of the heart. "These could be indwelling -- placed in patients where continuous measurements of pH might be an advantage," he says. "The electrode can be generated in any size or configuration."

The electrode?s sensing layer -- called AEIROF (anodic electrodeposited iridium oxide film) -- also may be used for monitoring pH in the esophagus and the gut. "The monitoring of pH in the gut has been shown useful in patients who have septic shock, an overwhelming bacterial infection," Cascio says. "Then there are people with peptic ulcer disease or clinical conditions involving overproduction of acid in the stomach. Gastroenterologists routinely measure this with special tubes, so you can see putting this type of electrode on the end of those tubes as well."

In their application for patent, the researchers note that the AEIROF electrodes will be inexpensive to produce and can be used alone or grouped with other biosensors such as potassium, glucose or lactate electrodes. "In general, the electrodes of the present invention may be used in many situations where standard glass pH electrodes are now used," they say.

Along with Cascio, other AEIROF collaborators in the UNC-CH department of medicine are Dr. Timothy A. Johnson and Larry Dunlap. From the department of chemistry are Dr. Sayed A. Marzouk, Stefan Ufer, and Dr. Richard P. Buck, a pioneer in biosensors. Supporting this research is a grant from the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
-end-
Note to media: Dr. Cascio can be reached at 919-966-5201 (email: wcascio@ischemia.card.unc.edu) A photograph of Dr. Cascio for publication is available.

UNC-CH School of Medicine contact: Lynn Wooten, 919-966-6046. Email: lwooten.est1@mail.unch.unc.edu. He may also assist you in obtaining copies of the report in Analytical Chemistry.



University of North Carolina Health Care

Related Septic Shock Articles from Brightsurf:

Early steroids improve outcomes in patients with septic shock
Some critically ill patients with septic shock need medications called vasopressors to correct dangerously low blood pressure.

Less aggressive treatment better for heart patients who go into shock
Less is sometimes more when treating heart patients who go into shock after a heart attack.

New testing system predicts septic shock outcomes
PME professor Savas Tay and his collaborators have developed a new, extremely sensitive method that can quantify bacteria, an antibiotic resistant gene, and immune molecule levels within sepsis patients, far more rapidly than current protocols.

Empty SV40 capsids increase survival of septic rats by eliciting numerous host signaling networks
The cover for issue 6 of Oncotarget features Figure 3, 'The effect of NCs treatments on routine lab results during disease and recovery progress,' by Ben-Nun-Shaul, et al.

At least 13% of wastewater treated by Southern Ontario septic systems ends up in streams
The presence of artificial sweeteners has revealed that at least 13 percent of septic system wastewater from rural Southern Ontario homes eventually makes its way into local streams.

Gene therapy success in chronic septic granulomatosis
American and British teams published yesterday in Nature Medicine the conclusive results of a gene therapy trial conducted in the United States and Great Britain in 9 patients with X-linked Chronic Septic Granulomatosis (X-CGD), a rare and severe immune dysfunction.

Vitamin C-B1-steroid combo linked to lower septic shock mortality in kids
Treating septic shock in children with a combination of intravenous vitamin C, vitamin B1 and hydrocortisone (a commonly used steroid) is associated with lower mortality, according to a study from Ann & Robert H.

VITAMINS trial report on vitamin C, hydrocortisone, thiamine for septic shock
In this randomized clinical trial of about 200 patients with septic shock, combination treatment with intravenous vitamin C, hydrocortisone and thiamine compared with intravenous hydrocortisone alone didn't significantly improve the amount of time patients were alive and free of medicines that raise blood pressure (vasopressors) over seven days.

Sphingotec's biomarker penKid® predicts septic acute kidney injury
Sphingotec reports study data demonstrating that its proprietary renal function biomarker penKid® (Proenkephalin) predicts acute kidney injury (AKI), multi-organ failure and mortality in sepsis patients presenting to the emergency department (ED).

Researchers create model to predict children likely to go into septic shock
Researchers at the University of Colorado Anschutz Medical Campus have developed a unique model allowing them to predict which children arriving in emergency departments are most likely to go into septic shock, a life-threatening condition.

Read More: Septic Shock News and Septic Shock Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.